Atlanta Wire: Atlanta News, Business & Entertainmen

BREAKING NEWS
Children's Healthcare Atlanta Peanut Allergy Microneedle Trial

Children’s Healthcare Of Atlanta Leads First-In-Human Peanut Allergy Trial Using Microneedle Technology From Atlanta-Based Moonlight Therapeutics

Children’s Healthcare of Atlanta has opened a first-in-human clinical trial testing whether a microneedle skin stamp the size of a nickel could change how peanut allergies are treated in the United States. The Phase 1 trial, designated SURVEYOR, is evaluating the safety and tolerability of MOON101, an investigational therapy developed by Atlanta-based biotech company Moonlight Therapeutics, Inc. The stainless steel stamp is coated with small doses of peanut protein and designed to be pressed against the forearm for approximately three minutes, delivering the allergen into the upper layers of the skin without any ingestion. Dr. Brian Vickery, Chief of Allergy and Immunology at Children’s Healthcare